The Digest’s 2025 Multi-Slide Guide to Novonesis
by Jim Lane (ReEnergize the Gulf Coast) Novonesis highlights its successful combination of Novozymes and Chr. Hansen in 2024, achieving 8% organic sales growth and a 36.1% adjusted EBITDA margin. The company reached 80% of its cost synergy run-rate in the